Premium
Mechanical Circulatory Support Devices for Pediatric Patients With Congenital Heart Disease
Author(s) -
Chopski Steven G.,
Moskowitz William B.,
Stevens Randy M.,
Throckmorton Amy L.
Publication year - 2017
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1111/aor.12760
Subject(s) - circulatory system , medicine , heart failure , heart disease , artificial heart , ventricular assist device , destination therapy , bridge (graph theory) , intensive care medicine , clinical trial , cardiology
The use of mechanical circulatory support (MCS) devices is a viable therapeutic treatment option for patients with congestive heart failure. Ventricular assist devices, cavopulmonary assist devices, and total artificial heart pumps continue to gain acceptance as viable treatment strategies for both adults and pediatric patients as bridge‐to‐transplant, bridge‐to‐recovery, and longer‐term circulatory support alternatives. We present a review of the current and future MCS devices for patients having congenital heart disease (CHD) with biventricular or univentricular circulations. Several devices that are specifically designed for patients with complex CHD are in the development pipeline undergoing rigorous animal testing as readiness experiments in preparation for future clinical trials. These advances in the development of new blood pumps for patients with CHD will address a significant unmet clinical need, as well as generally improve innovation of the current state of the art in MCS technology.